Literature DB >> 34961335

Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Paari Dominic1,2, Javaria Ahmad2, Hajra Awwab1,2, Md Shenuarin Bhuiyan1,3,4, Christopher G Kevil1,3,4,5, Nicholas E Goeders6, Kevin S Murnane6,7, James C Patterson7, Kristin E Sandau8, Rakesh Gopinathannair9, Brian Olshansky10.   

Abstract

Nonmedical use of prescription and nonprescription drugs is a worldwide epidemic, rapidly growing in magnitude with deaths because of overdose and chronic use. A vast majority of these drugs are stimulants that have various effects on the cardiovascular system including the cardiac rhythm. Drugs, like cocaine and methamphetamine, have measured effects on the conduction system and through several direct and indirect pathways, utilizing multiple second messenger systems, change the structural and electrical substrate of the heart, thereby promoting cardiac dysrhythmias. Substituted amphetamines and cocaine affect the expression and activation kinetics of multiple ion channels and calcium signaling proteins resulting in EKG changes, and atrial and ventricular brady and tachyarrhythmias. Preexisting conditions cause substrate changes in the heart, which decrease the threshold for such drug-induced cardiac arrhythmias. The treatment of cardiac arrhythmias in patients who take drugs of abuse may be specialized and will require an understanding of the unique underlying mechanisms and necessitates a multidisciplinary approach. The use of primary or secondary prevention defibrillators in drug abusers with chronic systolic heart failure is both sensitive and controversial. This review provides a broad overview of cardiac arrhythmias associated with stimulant substance abuse and their management.

Entities:  

Keywords:  amphetamines; arrhythmias; cocaine; ecstasy; methamphetamine

Mesh:

Substances:

Year:  2021        PMID: 34961335      PMCID: PMC8766923          DOI: 10.1161/CIRCEP.121.010273

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  129 in total

Review 1.  Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Authors:  Robert S Hoffman
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 2.  Treatment of cocaine cardiovascular toxicity: a systematic review.

Authors:  John R Richards; Dariush Garber; Erik G Laurin; Timothy E Albertson; Robert W Derlet; Ezra A Amsterdam; Kent R Olson; Edward A Ramoska; Richard A Lange
Journal:  Clin Toxicol (Phila)       Date:  2016-02-26       Impact factor: 4.467

3.  Targeted disruption of K(ATP) channels aggravates cardiac toxicity in cocaine abuse.

Authors:  Santiago Reyes; Garvan C Kane; Leonid V Zingman; Satsuki Yamada; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

4.  Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy.

Authors:  Robert J Henning; Javier Cuevas
Journal:  J Cardiovasc Pharmacol       Date:  2006-07       Impact factor: 3.105

5.  Amitriptyline and procainamide inhibition of cocaine and cocaethylene degradation in human serum in vitro.

Authors:  D N Bailey
Journal:  J Anal Toxicol       Date:  1999 Mar-Apr       Impact factor: 3.367

6.  Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.

Authors:  Marin Nishimura; Janet Ma; Sutton Fox; Avinash Toomu; Sean Mojaver; Derek K Juang; Alan S Maisel; Isac C Thomas
Journal:  Am J Cardiol       Date:  2019-06-26       Impact factor: 2.778

7.  3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Intoxication in a Young Adult with Giant Coronary Aneurysms from Kawasaki Disease.

Authors:  Renee Eigsti; Dennis J Firchau; Marcus B Nashelsky
Journal:  Acad Forensic Pathol       Date:  2018-08-31

8.  Acute myocardial infarction in young adults who abuse amphetamines.

Authors:  Arthur N Westover; Paul A Nakonezny; Robert W Haley
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

9.  Potential role of cardiac calsequestrin in the lethal arrhythmic effects of cocaine.

Authors:  Emiliano J Sanchez; Robert P Hayes; John T Barr; Kevin M Lewis; Brian N Webb; Arun K Subramanian; Mark S Nissen; Jeffrey P Jones; Eric A Shelden; Barbara A Sorg; Michael Fill; James O Schenk; Chulhee Kang
Journal:  Drug Alcohol Depend       Date:  2013-07-19       Impact factor: 4.492

10.  Lidocaine potentiation of cocaine toxicity.

Authors:  R W Derlet; T E Albertson; R S Tharratt
Journal:  Ann Emerg Med       Date:  1991-02       Impact factor: 5.721

View more
  1 in total

1.  Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities.

Authors:  Amber N Edinoff; Sarah E Kaufman; Keionne M Green; Daniel A Provenzano; Jesse Lawson; Elyse M Cornett; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.